MYD88 and diffuse large B-cell lymphoma: Our current data confirm that the oncogenic MYD88 L265P mutant induces strong MYD88 aggregation, IRAK1 phosphorylation and NF-κB activation in DLBCL cells (Fig. 2 and Fig. 3).